GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction: £3.75 Million Raised

30 Jun 2015 16:15

RNS Number : 7193R
Arria NLG PLC
30 June 2015
 

The following amendments have been made to the '£3.75 Million Raised' announcement released on 29 June 2015 at 7:32 a.m. under RNS No 4652R.

 

- The calculation of the number of B Warrants to be issued to the Loan Note holders has been clarified

- The Update of the Capital Structure table has been amended to correct an erroneous figure and highlight that some of the figures are approximations.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

 

ARRIA NLG PLC

 

 ("Arria" or the "Company")

 

£3.75 Million Raised

 

The Board of Arria (AIM:NLG) is very pleased to announce that the Company has worked with a number of existing shareholders and subscribers (the "Subscribers") to gain immediate access to approximately £3.75 million in capital funding through unsecured loan notes convertible to the Company's ordinary shares at 40p per share ("Loan Notes").

 

This funding comes as stage one of a two-stage capital plan being managed for Arria by MSL Capital Markets Limited ("MSL"), the New Zealand-based investment bank whose principals have acted as lead manager on each of Arria's successful private capital rounds. In an undertaking provided by Arria to MSL and the Subscribers, the Board has confirmed that it fully supports the two stage capital plan.

 

Stage 1: £3.75 Million in Loan Notes

 

Stage 1 of the capital plan (which addresses the Company's near to medium-term working capital requirements) comprises the acceleration of a drawdown of existing Loan Notes and the issue of new Loan Notes as follows:

 

· £1.848 million from The Ikonic Fund SAC (Bahamas) Limited ("Ikonic") by way of Ikonic agreeing to the early drawdown of the two installments still to be drawn down under the unsecured convertible loan note instrument between the Company and Ikonic dated 30 September 2014 (the "Ikonic Notes"). These amounts were not due for drawdown until 31 December 2015 and 31 March 2016. The Company has agreed to pay certain costs which Ikonic will incur in allowing the Company to drawdown earlier than originally agreed; and

 

· £1.902 million through subscriptions for the new Loan Notes from existing shareholders in the Company. The new Loan Notes have the same terms and conditions as the Ikonic Notes.

 

Subscribers for the new Loan Notes and Ikonic will receive unlisted warrants to subscribe for new ordinary shares in the Company, exercisable for a period of four years, at 12p per new ordinary share (the "B Warrants"). The Company will issue 6 million B Warrants to Ikonic, for the Ikonic Notes drawn down early and approximately 5.972 million B Warrants to the new convertible Loan Note holders. An additional one million B Warrants will be issued to MSL for services. The number of B Warrants issued to the new convertible Loan Note holders may fluctuate depending upon the GBP£/US$ exchange rate. This is because the quantum of B Warrants issued to the new convertible Loan Note holders is calculated on the basis of two B Warrants to every US$ of Loan Note subscribed.

 

The detailed terms of the Ikonic transaction were announced to the market on 1 October 2014. The following is a summary of terms common to both Loan Note programs.

 

· Interest at the Bank of England base rate (currently 0.5%) plus 5%, payable annually in cash or upon maturity.

 

· Maturity is 31 October 2019 with the Company having a right of payment before maturity.

 

· The conversion price is 40p per ordinary share. Holders can convert their principal and interest at any time before payment or maturity.

 

Stage 2: New Zealand Stock Exchange Listing

 

Stage 2 of the capital plan (which addresses the longer-term capital needs of the Company) is targeted for completion this year. It calls for MSL to organize a public offer and a listing of Arria's ordinary shares on the New Zealand Stock Exchange ("NZSX"). The Board will also consider alternative capital sources. Further announcements regarding fundraising will be made in due course.

 

Update of the Capital Structure

 

To ensure clarity and transparency of the Company's capital structure upon completion of Stage 1, the Company has prepared the following table showing the effect of the capital raise on the current position:

 

Arria NLG plc Securities

Nominal value

Note value

Number of shares

Existing ordinary shares

£103,729.21

103,729,210

Existing listed warrants

£10,085.58

10,085,583

The Ikonic Notes

-

£3.08 million

7,700,000(1)

The new Loan Notes

-

£1.902 million

4,755,000(1)

B Warrants

£12,972.28(2)

12,972,280(2)

(1) Assumes all loan notes are converted into Ordinary shares

(2) Assumes allotment at approximately US$1.57 / £, and all B Warrants are converted into Ordinary shares

The Board has authorized MSL to arrange subscriptions for up to a further £1.25 million of Loan Notes.

 

Emmanuel Alexiou, Executive Vice Chairman of Colina Insurance Limited (majority shareholder of The Ikonic Fund) said: "We are very pleased to support Arria's innovative two-stage capital program. With the loan notes convertible to shares at 40p, and with the addition of warrants at 12p, we are making a bold statement to the market: The long-term potential of Arria's NLG technologies is unaffected by short-term vagaries, and the two-stage program will provide the operating capital Arria needs to deliver its artificial intelligence solutions globally."

 

Stuart Rogers, Chairman and Chief Executive of Arria NLG, commented:

"I am delighted we have concluded this next stage of our capital raising, which provides stability and support to our current operations as it directly addresses our near to medium-term working capital requirements. The staff and Board wish to thank MSL, Ikonic and the founding shareholders for their participation in this capital raise. Such strong support of Arria's business direction is indicative of the participating shareholders' belief in the long term value proposition of Arria's Natural Language Generation technology."

 

Commercial Progress Update

 

The Company continues to gain clients at the rate of approximately one new client per month. Since the beginning of May, Arria has announced contracts with three new enterprise clients: a financial services group, a meteorological firm and a travel services company."

 

For further information, please visit www.arria.com or contact:

 

Arria NLG plc

Stuart Rogers - Chairman and Chief Executive

 

Tel +44 (0) 20 7100 4540

Allenby Capital - Nominated Adviser & Joint Broker

Nick Naylor

Jeremy Porter

James Reeve

 

Tel: +44 (0) 20 3328 5656

 

MSL Capital Markets - Lead Manager

Andrew McDouall

Justine Dunnett

Peter Lynds

 

Tel: +64 (0) 4 472 2716

Westhouse Securities - Joint Broker

Antonio Bossi

Robert Finlay

 

Tel: +44 (0) 20 7601 6100

IFC Advisory - Financial PR and IR

Tim Metcalfe

Graham Herring

 Tel: +44 (0) 20 3053 8671

tim.metcalfe@investor-focus.co.uk

graham.herring@investor-focus.co.uk

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEBLFXEQFFBBB
Date   Source Headline
19th Jan 20177:00 amRNSCompany update
6th Jan 201710:32 amRNSResult of General Meeting
19th Dec 20163:03 pmRNSRecount Product Launch UK
19th Dec 20167:00 amRNSProposed cancellation of trading on AIM
7th Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20168:45 amRNSTimetable and Progress to NZ and Australia IPO
21st Nov 20168:00 amRNSUpdate on Loan Note Subscriptions
7th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20164:14 pmRNSUpdate on trading and proposed NZX listing
24th Oct 20167:00 amRNSFinancing update
13th Oct 20168:30 amRNSDirectorate Changes
5th Oct 20167:00 amRNSProduct Launch - Articulator Lite
3rd Oct 20167:00 amRNSFinancing update
13th Sep 20167:00 amRNSPartnership agreement with GeoCosmo Sciences SPC
5th Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSProduct Launch
8th Aug 20167:00 amRNSBoard Changes
18th Jul 20168:00 amRNSIssue of Loan Notes
12th Jul 20167:00 amRNSFurther pilot programmes secured
4th Jul 20169:00 amRNSProposed NZSX & ASX listings
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 20167:29 amRNSHalf Year Results
10th Jun 20167:00 amRNSListing and fundraising update
1st Jun 20167:00 amRNSImplementation and Licence Agreement
26th May 20167:00 amRNSGrant of 9th US Patent
16th May 20167:00 amRNSGrant of 8th US Patent
21st Mar 201610:37 amRNSPartnership Agreement with INOVX
18th Mar 20164:40 pmRNSSecond Price Monitoring Extn
18th Mar 20164:35 pmRNSPrice Monitoring Extension
18th Mar 20161:57 pmRNSFundraising Update
25th Feb 20161:00 pmRNSGrant of 7th US Patent
23rd Feb 20161:06 pmRNSHolding(s) in Company
18th Feb 20162:48 pmRNSDirectorate Change
12th Feb 20164:20 pmRNSHolding(s) in Company
12th Feb 20164:20 pmRNSHolding(s) in Company
11th Feb 20165:05 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSGrant of 6th US Patent
29th Jan 20166:00 pmRNSTotal Voting Rights
28th Jan 201611:37 amRNSResult of AGM
25th Jan 20167:00 amRNSExercise of Options
11th Jan 20164:35 pmRNSPrice Monitoring Extension
11th Jan 20167:00 amRNSGrant of 5th US Patent
4th Jan 20167:00 amRNSFramework Agreement with Major US Utility Company
30th Dec 20157:00 amRNSGrant of Share Options
22nd Dec 20157:00 amRNSFramework Agreement with Genpact
11th Dec 20157:00 amRNSFinal Results for the year ended 30 September 2015
30th Nov 20155:40 pmRNSTotal Voting Rights
18th Nov 201511:54 amRNSUpdate on issue of convertible notes & warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.